Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.

BACKGROUND: At present, screening of the population at risk for gambiense human African trypanosomiasis (HAT) is based on detection of antibodies against native variant surface glycoproteins (VSGs) of Trypanosoma brucei (T.b.) gambiense. Drawbacks of these native VSGs include culture of infective T....

Full description

Bibliographic Details
Main Authors: Liesbeth Van Nieuwenhove, Philippe Büscher, Fatima Balharbi, Michael Humbert, Tessa Dieltjens, Yves Guisez, Veerle Lejon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3373652?pdf=render
_version_ 1818287827755991040
author Liesbeth Van Nieuwenhove
Philippe Büscher
Fatima Balharbi
Michael Humbert
Tessa Dieltjens
Yves Guisez
Veerle Lejon
author_facet Liesbeth Van Nieuwenhove
Philippe Büscher
Fatima Balharbi
Michael Humbert
Tessa Dieltjens
Yves Guisez
Veerle Lejon
author_sort Liesbeth Van Nieuwenhove
collection DOAJ
description BACKGROUND: At present, screening of the population at risk for gambiense human African trypanosomiasis (HAT) is based on detection of antibodies against native variant surface glycoproteins (VSGs) of Trypanosoma brucei (T.b.) gambiense. Drawbacks of these native VSGs include culture of infective T.b. gambiense trypanosomes in laboratory rodents, necessary for production, and the exposure of non-specific epitopes that may cause cross-reactions. We therefore aimed at identifying peptides that mimic epitopes, hence called "mimotopes," specific to T.b. gambiense VSGs and that may replace the native proteins in antibody detection tests. METHODOLOGY/PRINCIPAL FINDINGS: A Ph.D.-12 peptide phage display library was screened with polyclonal antibodies from patient sera, previously affinity purified on VSG LiTat 1.3 or LiTat 1.5. The peptide sequences were derived from the DNA sequence of the selected phages and synthesised as biotinylated peptides. Respectively, eighteen and twenty different mimotopes were identified for VSG LiTat 1.3 and LiTat 1.5, of which six and five were retained for assessment of their diagnostic performance. Based on alignment of the peptide sequences on the original protein sequence of VSG LiTat 1.3 and 1.5, three additional peptides were synthesised. We evaluated the diagnostic performance of the synthetic peptides in indirect ELISA with 102 sera from HAT patients and 102 endemic negative controls. All mimotopes had areas under the curve (AUCs) of ≥0.85, indicating their diagnostic potential. One peptide corresponding to the VSG LiTat 1.3 protein sequence also had an AUC of ≥0.85, while the peptide based on the sequence of VSG LiTat 1.5 had an AUC of only 0.79. CONCLUSIONS/SIGNIFICANCE: We delivered the proof of principle that mimotopes for T.b. gambiense VSGs, with diagnostic potential, can be selected by phage display using polyclonal human antibodies.
first_indexed 2024-12-13T01:46:41Z
format Article
id doaj.art-9f32787d3284478c955496a9739a74db
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-13T01:46:41Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-9f32787d3284478c955496a9739a74db2022-12-22T00:03:37ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352012-01-0166e168210.1371/journal.pntd.0001682Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.Liesbeth Van NieuwenhovePhilippe BüscherFatima BalharbiMichael HumbertTessa DieltjensYves GuisezVeerle LejonBACKGROUND: At present, screening of the population at risk for gambiense human African trypanosomiasis (HAT) is based on detection of antibodies against native variant surface glycoproteins (VSGs) of Trypanosoma brucei (T.b.) gambiense. Drawbacks of these native VSGs include culture of infective T.b. gambiense trypanosomes in laboratory rodents, necessary for production, and the exposure of non-specific epitopes that may cause cross-reactions. We therefore aimed at identifying peptides that mimic epitopes, hence called "mimotopes," specific to T.b. gambiense VSGs and that may replace the native proteins in antibody detection tests. METHODOLOGY/PRINCIPAL FINDINGS: A Ph.D.-12 peptide phage display library was screened with polyclonal antibodies from patient sera, previously affinity purified on VSG LiTat 1.3 or LiTat 1.5. The peptide sequences were derived from the DNA sequence of the selected phages and synthesised as biotinylated peptides. Respectively, eighteen and twenty different mimotopes were identified for VSG LiTat 1.3 and LiTat 1.5, of which six and five were retained for assessment of their diagnostic performance. Based on alignment of the peptide sequences on the original protein sequence of VSG LiTat 1.3 and 1.5, three additional peptides were synthesised. We evaluated the diagnostic performance of the synthetic peptides in indirect ELISA with 102 sera from HAT patients and 102 endemic negative controls. All mimotopes had areas under the curve (AUCs) of ≥0.85, indicating their diagnostic potential. One peptide corresponding to the VSG LiTat 1.3 protein sequence also had an AUC of ≥0.85, while the peptide based on the sequence of VSG LiTat 1.5 had an AUC of only 0.79. CONCLUSIONS/SIGNIFICANCE: We delivered the proof of principle that mimotopes for T.b. gambiense VSGs, with diagnostic potential, can be selected by phage display using polyclonal human antibodies.http://europepmc.org/articles/PMC3373652?pdf=render
spellingShingle Liesbeth Van Nieuwenhove
Philippe Büscher
Fatima Balharbi
Michael Humbert
Tessa Dieltjens
Yves Guisez
Veerle Lejon
Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
PLoS Neglected Tropical Diseases
title Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
title_full Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
title_fullStr Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
title_full_unstemmed Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
title_short Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
title_sort identification of mimotopes with diagnostic potential for trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions
url http://europepmc.org/articles/PMC3373652?pdf=render
work_keys_str_mv AT liesbethvannieuwenhove identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions
AT philippebuscher identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions
AT fatimabalharbi identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions
AT michaelhumbert identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions
AT tessadieltjens identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions
AT yvesguisez identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions
AT veerlelejon identificationofmimotopeswithdiagnosticpotentialfortrypanosomabruceigambiensevariantsurfaceglycoproteinsusinghumanantibodyfractions